Inhibition of p38-MK2 pathway enhances the efficacy of microtubule inhibitors in breast cancer cells
Microtubule-targeting agents (MTAs) are widely used as first- and second-line chemotherapies for various cancers. However, current MTAs exhibit positive responses only in subsets of patients and are often accompanied by side effects due to their impact on normal cells. This underscores an urgent nee...
-д хадгалсан:
| Үндсэн зохиолчид: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Хэл сонгох: | Inglês |
| Хэвлэсэн: |
eLife Sciences Publications Ltd
2025-05-01
|
| Цуврал: | eLife |
| Нөхцлүүд: | |
| Онлайн хандалт: | https://elifesciences.org/articles/104859 |
| Шошгууд: |
Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!
|